Foghorn Therapeutics (FHTX) Invested Capital (2020 - 2025)
Foghorn Therapeutics (FHTX) has 6 years of Invested Capital data on record, last reported at -$108.5 million in Q4 2025.
- For Q4 2025, Invested Capital fell 138.31% year-over-year to -$108.5 million; the TTM value through Dec 2025 reached -$108.5 million, down 138.31%, while the annual FY2025 figure was -$108.5 million, 138.31% down from the prior year.
- Invested Capital reached -$108.5 million in Q4 2025 per FHTX's latest filing, down from -$89.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $125.5 million in Q1 2021 and bottomed at -$108.5 million in Q4 2025.
- Average Invested Capital over 5 years is -$6.9 million, with a median of -$26.4 million recorded in 2023.
- Peak YoY movement for Invested Capital: surged 223.97% in 2021, then plummeted 69019.64% in 2023.
- A 5-year view of Invested Capital shows it stood at $96.9 million in 2021, then plummeted by 99.88% to $112000.0 in 2022, then tumbled by 69019.64% to -$77.2 million in 2023, then surged by 41.02% to -$45.5 million in 2024, then crashed by 138.31% to -$108.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Invested Capital were -$108.5 million in Q4 2025, -$89.7 million in Q3 2025, and -$76.7 million in Q2 2025.